ACR (American College of Rheumatology) responsraten i forsøg YU203 var 27, 7% for placebo, 31, 9% for 5 mg, 50, 5% for 10 mg og 54, 4% for 25 mg daglig.
The ACR (American College of Rheumatology) response rates in study YU203 were 27.7% for placebo, 31.9% for 5 mg, 50.5% for 10 mg and 54.5% 11 for 25 mg/ day.